CRISPR-edited CAR T cells enhance fight against blood cancers

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainKnocking out a protein known to stifle T cell activation on CAR T cells using the CRISPR/Cas9 technology e

Updated on: April 12,2024

CRISPR-edited CAR T cells enhance fight against blood cancers

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainKnocking out a protein known to stifle T cell activation on CAR T cells using the CRISPR/Cas9 technology e

Updated on:April 12,2024

Liver cancer growth tied to tryptophan intake

byUTSouthwestern Medical CenterSummary of our findings on Trp dependency and vulnerability in MYC-driven tumors. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-478

Updated on: August 27,2024

Liver cancer growth tied to tryptophan intake

byUTSouthwestern Medical CenterSummary of our findings on Trp dependency and vulnerability in MYC-driven tumors. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-478

Updated on:August 27,2024

Experimental AI method boosts doctors' ability to diagnose cancers and precancers of the esophagus

by Delthia Ricks , Medical XpressEndoscopic photographs of lesions in three false-negative patients. Credit:Science Translational Medicine(2024). DOI: 10.1126/scitranslmed.adk5395Artificia

Updated on: August 27,2024

Experimental AI method boosts doctors' ability to diagnose cancers and precancers of the esophagus

by Delthia Ricks , Medical XpressEndoscopic photographs of lesions in three false-negative patients. Credit:Science Translational Medicine(2024). DOI: 10.1126/scitranslmed.adk5395Artificia

Updated on:August 27,2024

Blood test for brain cancer may be on horizon, research finds

byPennsylvania State UniversityCredit: Pixabay/CC0 Public DomainGlioblastoma (GBM) is the most common and deadliest type of brain cancer with a five-year survival rate of only 5%. Researchers at

Updated on: January 23,2024

Blood test for brain cancer may be on horizon, research finds

byPennsylvania State UniversityCredit: Pixabay/CC0 Public DomainGlioblastoma (GBM) is the most common and deadliest type of brain cancer with a five-year survival rate of only 5%. Researchers at

Updated on:January 23,2024

Hair straightening chemicals associated with higher uterine cancer risk

byNational Institutes of HealthCredit: Pixabay/CC0 Public DomainWomen who used chemical hair straightening products were at higher risk for uterine cancer compared to women who did not report us

Updated on: December 28,2023

Hair straightening chemicals associated with higher uterine cancer risk

byNational Institutes of HealthCredit: Pixabay/CC0 Public DomainWomen who used chemical hair straightening products were at higher risk for uterine cancer compared to women who did not report us

Updated on:December 28,2023

AI-Assisted Histopathology: Refining the Distinction Between Sebaceous and Squamous Cell Carcinoma of the Eyelid

Updated on: August 30,2025

AI-Assisted Histopathology: Refining the Distinction Between Sebaceous and Squamous Cell Carcinoma of the Eyelid

Updated on:August 30,2025

Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer

by Impact Journals LLCVolcano plot of significant differentially expressed genes with the left volcano being the discovery cohort and validation cohort on the right. Credit:Oncotarget(2022

Updated on: January 02,2024

Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer

by Impact Journals LLCVolcano plot of significant differentially expressed genes with the left volcano being the discovery cohort and validation cohort on the right. Credit:Oncotarget(2022

Updated on:January 02,2024

Study links gut microbiome and aggressive prostate cancer

by Cleveland ClinicCredit: CC0 Public DomainCleveland Clinic researchers have shown for the first time that diet-associated molecules in the gut are associated with aggressive prostate cancer, su

Updated on: April 20,2024

Study links gut microbiome and aggressive prostate cancer

by Cleveland ClinicCredit: CC0 Public DomainCleveland Clinic researchers have shown for the first time that diet-associated molecules in the gut are associated with aggressive prostate cancer, su

Updated on:April 20,2024

ACE inhibitor not protective against heart damage from chemotherapy

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainPatients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment with high-dose anthracyclin

Updated on: April 28,2024

ACE inhibitor not protective against heart damage from chemotherapy

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainPatients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment with high-dose anthracyclin

Updated on:April 28,2024

Bladder cancer treatment can be better targeted and more effective, trials show

by European Association of UrologyCredit: Unsplash/CC0 Public DomainTesting for tumor DNA in the blood can successfully identify advanced bladder cancer patients who will not relapse following su

Updated on: April 06,2024

Bladder cancer treatment can be better targeted and more effective, trials show

by European Association of UrologyCredit: Unsplash/CC0 Public DomainTesting for tumor DNA in the blood can successfully identify advanced bladder cancer patients who will not relapse following su

Updated on:April 06,2024

How to lower your risk of breast cancer recurrence

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainMost women treated for breast cancer have something else in common: they worry about the cancer coming back.

Updated on: January 02,2024

How to lower your risk of breast cancer recurrence

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainMost women treated for breast cancer have something else in common: they worry about the cancer coming back.

Updated on:January 02,2024

Drug combination shows promise in preclinical models of triple negative breast cancer

by Alhaji Janneh,Medical University of South CarolinaYueying Liu and Dr. Antonio Giordano study PLK1 inhibitors, traffic light-like signals that stop the uncontrolled growth of breast cancer cel

Updated on: May 23,2024

Drug combination shows promise in preclinical models of triple negative breast cancer

by Alhaji Janneh,Medical University of South CarolinaYueying Liu and Dr. Antonio Giordano study PLK1 inhibitors, traffic light-like signals that stop the uncontrolled growth of breast cancer cel

Updated on:May 23,2024